Michelle Moreton

467 total citations
11 papers, 371 citations indexed

About

Michelle Moreton is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Michelle Moreton has authored 11 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Transplantation, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Pharmacology. Recurrent topics in Michelle Moreton's work include Renal Transplantation Outcomes and Treatments (6 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Michelle Moreton is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Michelle Moreton collaborates with scholars based in United Kingdom, Austria and Ghana. Michelle Moreton's co-authors include David W. Holt, Salim Fredericks, Nicholas D. Carter, Iain MacPhee, A. E. Johnston, Lawrence Goldberg, Maha Mohamed, Ken A. van Someren, Gregory P. Whyte and Denise A. McKeown and has published in prestigious journals such as Transplantation, Journal of Antimicrobial Chemotherapy and Clinical Biochemistry.

In The Last Decade

Michelle Moreton

11 papers receiving 361 citations

Peers

Michelle Moreton
R J Ptachcinski United States
Pål Falck Norway
Louise M. Andrews Netherlands
Ian S Westley Australia
N. Undre United Kingdom
J van Hooff Netherlands
Dawn Harper United States
Michelle Moreton
Citations per year, relative to Michelle Moreton Michelle Moreton (= 1×) peers Miwa Uesugi

Countries citing papers authored by Michelle Moreton

Since Specialization
Citations

This map shows the geographic impact of Michelle Moreton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Moreton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Moreton more than expected).

Fields of papers citing papers by Michelle Moreton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Moreton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Moreton. The network helps show where Michelle Moreton may publish in the future.

Co-authorship network of co-authors of Michelle Moreton

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Moreton. A scholar is included among the top collaborators of Michelle Moreton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Moreton. Michelle Moreton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Fisher, D., Jacob Plange‐Rhule, Michelle Moreton, et al.. (2016). CYP3A5 as a candidate gene for hypertension: no support from an unselected indigenous West African population. Journal of Human Hypertension. 30(12). 778–782. 4 indexed citations
2.
Moreton, Michelle, et al.. (2010). THE INFLUENCE OF ABCB1 GENOTYPE ON BLOOD SIROLIMUS CONCENTRATIONS FOLLOWING SWITCH FROM A CALCINEURIN INHIBITOR. Transplantation. 90. 636–636. 1 indexed citations
3.
Jamshidi, Yalda, Michelle Moreton, Denise A. McKeown, et al.. (2010). Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection. Journal of Antimicrobial Chemotherapy. 65(12). 2614–2619. 26 indexed citations
4.
Whyte, Gregory P., et al.. (2008). The effects of a graduated aerobic exercise programme on cardiovascular disease risk factors in the NHS workplace: a randomised controlled trial. Journal of Occupational Medicine and Toxicology. 3(1). 7–7. 25 indexed citations
5.
Moreton, Michelle, et al.. (2008). THE INFLUENCE OF CYP3A5 GENOTYPE ON BLOOD SIROLIMUS CONCENTRATIONS FOLLOWING SWITCH FROM A CALCINEURIN INHIBITOR. Transplantation. 86(2S). 332–332. 1 indexed citations
6.
Fredericks, Salim, Iain MacPhee, Michelle Moreton, et al.. (2007). Multi‐drug resistance gene‐1 (MDR‐1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurements. Clinical Transplantation. 21(2). 252–257. 27 indexed citations
7.
Fredericks, Salim, Michelle Moreton, Nicholas D. Carter, et al.. (2006). Multidrug Resistance Gene-1 (MDR-1) Haplotypes Have a Minor Influence on Tacrolimus Dose Requirements. Transplantation. 82(5). 705–708. 56 indexed citations
8.
Wilson, David H., David Holt, Michelle Moreton, et al.. (2006). Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus. Clinical Biochemistry. 39(4). 378–386. 23 indexed citations
9.
MacPhee, Iain, Salim Fredericks, Maha Mohamed, et al.. (2005). Tacrolimus Pharmacogenetics: The CYP3A5*1 Allele Predicts Low Dose-Normalized Tacrolimus Blood Concentrations in Whites and South Asians. Transplantation. 79(4). 499–502. 175 indexed citations
10.
Holt, David W., et al.. (2005). A microparticle enzyme immunoassay to measure sirolimus. Transplantation Proceedings. 37(1). 182–184. 17 indexed citations
11.
Fredericks, Salim, Michelle Moreton, Iain MacPhee, et al.. (2005). Genotyping cytochrome P450 3A5 using the Light Cycler. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 42(5). 376–381. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026